Short interest edges down while options skew turns heavily protective. Three major analyst firms raised price targets Thursday — Stephens hitting $210 — as Enova heads into Tuesday's after-hours report with quarterly momentum on its side.
Short interest stands at 1.89M shares, or 7.6% of the float, as of April 23. Shares short ticked up 0.2% day-over-day but fell 0.9% over the past week. Cost to borrow dropped to 0.37% from 0.44% a week earlier. Utilization sits at just 1.4%, well below the 52-week high of 6.0%. Days to cover reached 10.6 in the latest FINRA fortnightly. The modest short position and low CTB suggest bears remain cautious but not aggressive.
Put-call ratio hit 9.26 on April 24, a fresh 52-week high and nearly 3 standard deviations above the 20-day mean of 6.55. The PCR has climbed steadily from around 6 in late March. Heavy put buying points to demand for downside protection ahead of earnings, though it may also reflect outright bearish positioning.
Analyst consensus is unavailable, but the mean price target sits at $197.71. Three firms raised targets on April 24. Stephens' Kyle Joseph lifted his Overweight target to $210 from $185. Citizens' David Scharf raised to $195 from $182, maintaining Market Outperform. TD Cowen's Moshe Orenbuch moved to $190 from $165, reiterating Buy. BTIG's Vincent Caintic held at Buy and $199 on April 23. Benzinga's bull case highlights a 32% year-over-year jump in Q4 originations and strong small business lending growth, with the pending Grasshopper Bancorp acquisition expected to drive 20%+ origination growth in 2026. The bear case warns of M&A execution risk and potential credit deterioration in the sub-prime segment.
P/E stands at 10.1, up 1.8 points over the past month. P/B reached 2.15, up 0.07 month-over-month. EPS momentum ranks in the 79th percentile over 90 days and 61st over 30 days. Analyst recommendation differential ranks at the 48th percentile. EPS surprise scores 53rd percentile.
Insiders sold $19.9M net over the past 90 days, with Executive Chairman David Fisher offloading $1.1M in mid-February. BlackRock holds 16.8% of shares, Vanguard 8.6%. T. Rowe Price added 447,863 shares in Q1, lifting its stake to 3.3%.
The company last reported on January 27, 2026. Prior prints landed in late April and late January of recent cycles. The stock is up 21.3% over the past month and 2.4% over the past week.
No ORTEX Alpha signals are currently active.
See the live data behind this article on ORTEX.
Open ENVA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
